node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
BCL2 | BCL2L1 | ENSBTAP00000025701 | ENSBTAP00000070613 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | BCL2-like 1 transcript variant 1. | 0.966 |
BCL2 | BID | ENSBTAP00000025701 | ENSBTAP00000040367 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | 0.994 |
BCL2 | CTSD | ENSBTAP00000025701 | ENSBTAP00000010022 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | Cathepsin D; Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation; Belongs to the peptidase A1 family. | 0.948 |
BCL2 | CTSF | ENSBTAP00000025701 | ENSBTAP00000014587 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | Cathepsin F; Belongs to the peptidase C1 family. | 0.900 |
BCL2L1 | BCL2 | ENSBTAP00000070613 | ENSBTAP00000025701 | BCL2-like 1 transcript variant 1. | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | 0.966 |
BCL2L1 | BID | ENSBTAP00000070613 | ENSBTAP00000040367 | BCL2-like 1 transcript variant 1. | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | 0.983 |
BCL2L1 | CTSD | ENSBTAP00000070613 | ENSBTAP00000010022 | BCL2-like 1 transcript variant 1. | Cathepsin D; Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation; Belongs to the peptidase A1 family. | 0.909 |
BCL2L1 | CTSF | ENSBTAP00000070613 | ENSBTAP00000014587 | BCL2-like 1 transcript variant 1. | Cathepsin F; Belongs to the peptidase C1 family. | 0.906 |
BID | BCL2 | ENSBTAP00000040367 | ENSBTAP00000025701 | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | 0.994 |
BID | BCL2L1 | ENSBTAP00000040367 | ENSBTAP00000070613 | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | BCL2-like 1 transcript variant 1. | 0.983 |
BID | CTSD | ENSBTAP00000040367 | ENSBTAP00000010022 | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | Cathepsin D; Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation; Belongs to the peptidase A1 family. | 0.920 |
BID | CTSF | ENSBTAP00000040367 | ENSBTAP00000014587 | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | Cathepsin F; Belongs to the peptidase C1 family. | 0.901 |
CLN3 | CLN5 | ENSBTAP00000023952 | ENSBTAP00000025093 | Battenin. | Ceroid-lipofuscinosis neuronal protein 5, secreted form; Plays a role in influencing the retrograde trafficking of lysosomal sorting receptors SORT1 and IGF2R from the endosomes to the trans-Golgi network by controlling the recruitment of retromer complex to the endosomal membrane. Regulates the localization and activation of RAB7A which is required to recruit the retromer complex to the endosomal membrane; Belongs to the CLN5 family. | 0.921 |
CLN3 | CLN6 | ENSBTAP00000023952 | ENSBTAP00000007315 | Battenin. | CLN6 transmembrane ER protein. | 0.923 |
CLN3 | CLN8 | ENSBTAP00000023952 | ENSBTAP00000068985 | Battenin. | TLC domain-containing protein. | 0.874 |
CLN3 | CTSD | ENSBTAP00000023952 | ENSBTAP00000010022 | Battenin. | Cathepsin D; Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation; Belongs to the peptidase A1 family. | 0.785 |
CLN3 | CTSF | ENSBTAP00000023952 | ENSBTAP00000014587 | Battenin. | Cathepsin F; Belongs to the peptidase C1 family. | 0.734 |
CLN3 | MFSD8 | ENSBTAP00000023952 | ENSBTAP00000074386 | Battenin. | Major facilitator superfamily domain containing 8. | 0.861 |
CLN5 | CLN3 | ENSBTAP00000025093 | ENSBTAP00000023952 | Ceroid-lipofuscinosis neuronal protein 5, secreted form; Plays a role in influencing the retrograde trafficking of lysosomal sorting receptors SORT1 and IGF2R from the endosomes to the trans-Golgi network by controlling the recruitment of retromer complex to the endosomal membrane. Regulates the localization and activation of RAB7A which is required to recruit the retromer complex to the endosomal membrane; Belongs to the CLN5 family. | Battenin. | 0.921 |
CLN5 | CLN6 | ENSBTAP00000025093 | ENSBTAP00000007315 | Ceroid-lipofuscinosis neuronal protein 5, secreted form; Plays a role in influencing the retrograde trafficking of lysosomal sorting receptors SORT1 and IGF2R from the endosomes to the trans-Golgi network by controlling the recruitment of retromer complex to the endosomal membrane. Regulates the localization and activation of RAB7A which is required to recruit the retromer complex to the endosomal membrane; Belongs to the CLN5 family. | CLN6 transmembrane ER protein. | 0.946 |